RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 95 filers reported holding RELAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,317,324 | -35.8% | 394,450 | -4.1% | 0.00% | -25.0% |
Q2 2023 | $5,166,029 | -24.5% | 411,308 | -1.0% | 0.00% | -33.3% |
Q1 2023 | $6,845,970 | +10.5% | 415,663 | +0.3% | 0.01% | 0.0% |
Q4 2022 | $6,192,958 | -31.6% | 414,522 | +2.4% | 0.01% | -33.3% |
Q3 2022 | $9,051,000 | +146.1% | 404,620 | +84.2% | 0.01% | +125.0% |
Q2 2022 | $3,678,000 | -49.7% | 219,622 | -10.1% | 0.00% | -20.0% |
Q1 2022 | $7,311,000 | +5.8% | 244,277 | +8.5% | 0.01% | +25.0% |
Q4 2021 | $6,911,000 | +2.9% | 225,041 | +5.6% | 0.00% | 0.0% |
Q3 2021 | $6,718,000 | -4.6% | 213,089 | +10.7% | 0.00% | +33.3% |
Q2 2021 | $7,044,000 | +18.9% | 192,521 | +12.4% | 0.00% | 0.0% |
Q1 2021 | $5,922,000 | +78.3% | 171,286 | +114.3% | 0.00% | +50.0% |
Q4 2020 | $3,322,000 | -92.2% | 79,932 | -98.6% | 0.00% | -93.1% |
Q3 2020 | $42,506,000 | – | 5,664,921 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
Grace Capital | 164,389 | $6,832,000 | 4.32% |
Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |